Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07020533
What this trial is testing

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+9 more
City of Hope Medical Center 46
Testing effectiveness (Phase 2)Study completedNCT00899847
What this trial is testing

Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

Who this might be right for
Transplantation, HomologousTransplantation, AutologousMultiple Myeloma+1 more
Stanford University 9
Testing effectiveness (Phase 2)Ended earlyNCT01573247
What this trial is testing

Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia
Akinion Pharmaceuticals AB 25
Not applicableStudy completedNCT01542749
What this trial is testing

Total Body Albumin Measurement Utilizing a Modification of the BVA 100 Blood Volume Analyzer

Who this might be right for
HypoalbuminemiaHeart FailureNephrosis+2 more
Daxor Corporation 20
Not applicableStudy completedNCT03161626
What this trial is testing

Registry Study of COAGADEX® Patients With Moderate or Severe Hereditary Factor X Deficiency Undergoing Major Surgery

Who this might be right for
Factor 10 Deficiency
Bio Products Laboratory 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT04980885
What this trial is testing

A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Akeso 68
Not applicableStudy completedNCT00720317
What this trial is testing

Diabetic Retinopathy and Sickle Trait

Who this might be right for
Diabetic RetinopathySickle Cell Trait
Medical University of South Carolina 48
Testing effectiveness (Phase 2)Looking for participantsNCT06517017
What this trial is testing

Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
University of Utah 40
Early research (Phase 1)Study completedNCT05470140
What this trial is testing

WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Allotera Therapeutics 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT01885689
What this trial is testing

Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia in Remission+4 more
City of Hope Medical Center
Not applicableLooking for participantsNCT04018118
What this trial is testing

Natural History of Hypereosinophilia and Hypereosinophilic Syndromes

Who this might be right for
EosinophiliaHypereosinophilic Syndrome
University Hospital, Lille 600
Testing effectiveness (Phase 2)Study completedNCT00019097
What this trial is testing

Vaccine Therapy in Treating Patients With Multiple Myeloma

Who this might be right for
Stage II Multiple MyelomaStage III Multiple MyelomaRefractory Plasma Cell Neoplasm
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00771810
What this trial is testing

Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer

Who this might be right for
ThrombocytopeniaNeutropeniaLymphopenia+1 more
Tarix Pharmaceuticals 34
Post-approval studies (Phase 4)Study completedNCT02232113
What this trial is testing

Frequent Dosing of CERA Improves Nutrition and Inflammation in Hemodialysis Patients

Who this might be right for
AnemiaInflammationMalnutrition
Taipei Veterans General Hospital, Taiwan 67
Testing effectiveness (Phase 2)Study completedNCT02210858
What this trial is testing

Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders

Who this might be right for
Accelerated Phase of DiseaseAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Myelogenous Leukemia, BCR-ABL1 Positive+4 more
National Cancer Institute (NCI) 31
Early research (Phase 1)Active Not RecruitingNCT02477878
What this trial is testing

Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant

Who this might be right for
LeukemiaMyelodysplastic SyndromesLymphoma+2 more
Bellicum Pharmaceuticals 10
Early research (Phase 1)Study completedNCT02485535
What this trial is testing

Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant

Who this might be right for
Acute Myeloid Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+2 more
University of Chicago 12
Very early researchUnknownNCT02937376
What this trial is testing

Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise

Who this might be right for
G6PD Deficiency
University of Thessaly 12
Not applicableLooking for participantsNCT00005917
What this trial is testing

Study of Chediak-Higashi Syndrome

Who this might be right for
Chediak-Higashi Syndrome
National Human Genome Research Institute (NHGRI) 60
Testing effectiveness (Phase 2)Study completedNCT01050855
What this trial is testing

Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders

Who this might be right for
Non Malignant DiseasesImmunodeficienciesHemoglobinopathies
Children's Hospital of Philadelphia 56
Next Page
72